Using immunohistochemistry (IHC) and immunoreactivity scoring system (IRS), we examined the expression level of AQP3 protein in breast invasive ductal carcinoma samples obtained from 56 patients. This evidence concerns the gene AQP3 and invasive ductal breast carcinoma.